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Throughput efficiency and service quality after process redesign at a cancer daycare 
unit: Two sides of the same coin? 
 
Abstract  
Objective: This study was designed to focus on the patient perspective in a reorganization of 
care processes at a cancer daycare unit (CDU). The effects of dose banding and of taking blood 
samples one day (or more) before the daycare treatment (on day -1) is investigated in terms of 
throughput efficiency and perceived service quality.  
Methods: Data were collected by mapping patient processes in detail and surveying patients in 
two CDUs at a university hospital (n = 308). A univariate model was used to investigate the 
effect of these factors on patient throughput time, and perceived service quality was examined 
with multiple linear regression.  
Results: Taking blood samples on day -1 decreases patient throughput time and increases the 
perceived service quality by improving the patient’s perception of technical expertise and the 
outcome. This has a globally positive effect on patients’ perceived service quality. Dose 
banding affected neither patient throughput time nor perceived service quality.  
Conclusion: Taking the pretreatment blood sample on day -1 can be considered an important 
process design characteristic, as it increases both efficiency and service quality.  
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Introduction 
There has been a considerable shift in cancer care from inpatient admissions to more 
outpatient visits and ambulatory care (Berglund, Gustafsson, Johansson & Bergenmar, 2015). 
This results in a higher number of patients being treated in daycare and highlights the need for 
increased timeliness and efficiency at cancer daycare units (CDUs). As a result, concepts such 
as lean and business process management are making their way into the sector 
(D’Andreamatteo, Ianni, Lega & Sargiacomo, 2015; Manfreda, Kovacic, Štemberger & 
Trkman, 2014). These studies have led to several suggestions for improvement, such as 
collecting the blood samples during an outpatient visit one or more days before the daycare 
treatment (day -1), in order to prepare the anticancer medication in advance. This leads to a 
reduction in patient throughput time in the CDU on the day of treatment (day 0) and increases 
the number of patients that can be treated per day (van Lent, Goedbloed & Van Harten, 2009). 
Another approach to reducing throughput time is dose banding (Huertas et al., 2015; Masselink, 
van der Mijden, Litvak & Vanberkel, 2012), which refers to a method that uses predefined 
ranges (bands) of body surface area (BSA) to calculate each patient’s dose as a single BSA 
value per band. This principle can only be applied to drugs with sufficient long-term stability. 
Dose banding and taking the blood sample on day -1 can both be considered process redesign 
initiatives. 
Despite the growing recognition and acceptance of the need to embrace patient-centred 
care approaches (Masselink et al., 2012), healthcare studies have paid limited attention to the 
patient perspective in process redesign initiatives (Moraros, Lemstra & Nwankwo, 2016). Most 
studies have focused merely on the collection of operational metrics, such as patient throughput 
time and the number of operational failures (McIntosh, Sheppy & Cohen, 2014), but have 
neglected ‘the patient’s perspective’ as a measure. This study instead aims to integrate the 
patient perspective into the operational analysis and design of hospital processes in cancer care.  
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The objective of this study is to measure the effect of dose banding and taking the blood sample 
on day -1 in two CDUs on both the throughput efficiency of the department and on the service 
quality perceived by patients. The efficiency will be studied by examining throughput time from 
the arrival of the patient in the CDU to the initiation of therapy. The perceived service quality 
is examined by means of a patient survey investigating patients’ opinion of the service quality 
of the department. This study investigates whether this process redesign at the CDU results in 
an improved service quality as perceived by the patient.  
Method 
Procedure 
Data were collected during one week in April 2015 (n = 163) and one week in November 
2015 (n = 145) at two CDUs in a university hospital. The study was approved by the medical 
ethics committee. Observations, document analysis, and six semistructured interviews were 
carried out in order to develop a process travel sheet for each department. Each patient process 
was documented by filling out the process travel sheet. CDU staff and the hospital pharmacy 
collected time and process data on each patient. Patients filled out a survey coupled to the 
process travel sheets in order to collect data from the patient perspective. Data from 780 patient 
processes were gathered. Data from the survey was available for 40% of these processes, as 
patients visited the clinic twice, and left out data in the responses. 
Measures 
The process travel sheet followed the patient process in the CDU to collect data on time 
points in the treatment process (e.g., arrival in the department, contact with the physician, and 
initiation of treatment). The travel sheet also identified whether the patient’s blood sample was 
taken on day -1 or on day 0. Data related to the process of anticancer drug preparation at the 
pharmacy were also collected and allowed us to identify whether dose banding was used. Other 
variables gathered on the process travel sheets were the CDU, the cancer type, and the type of 
 4 
medication. The service quality scale of Dagger et al. (2007) was used to record the perception 
of patients. Perceptions of four service quality dimensions (see Figure 1) were measured by 
means of a seven-point Likert scale (Dagger et al., 2007): Interpersonal quality reflects the 
interaction and the relationship over time between the service provider and the patient. 
Technical quality covers the professional competences of the service providers and the 
outcome. Environmental quality defines the complex mix of environmental features that shape 
the perceptions of patients, such as the atmosphere. Administrative quality relates to the 
supporting nonclinical and clinical services that facilitate the delivery of the core service.  
Figure 1: Dimensions of service quality, based on Dagger et al. (2007) 
------------------------------- 
 
Insert Figure 1 about here 
------------------------------- 
Statistical Analysis 
Since the data were not normally distributed (Kolmogorov–Smirnoff test: p < 0.05), a 
log transformation was performed for patient throughput time and perception variables were 
centralized. The validity of the constructs was assessed using confirmatory factor analysis. The 
measurement model for the sample performed well without the operational subdimension. The 
sample showed convergent validity and adequate construct validity. Since the measurement 
model performed well, in the further analysis we used mean scores for interpersonal quality, 
technical quality, environmental quality, administrative quality, and the perceived service 
satisfaction in relation to the CDU.  
The effect of the new process characteristics (dose banding and taking the blood sample 
on day -1) on waiting time was statistically evaluated using a general univariate linear model 
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with the univariate GLM dialog (Levene’s test: p = .148) with the factors dose banding (two 
factors) and day of blood sample (two factors). The effect of the quality dimensions of service 
quality and redesign characteristics on perceived service quality were analysed using multiple 
linear regression.  
Results 
The descriptive results show a difference in population between the two departments 
(see Table 1). In 14.9% of processes, medication was prepared by dose banding, and in 41.9% 
of the cases the blood sample was taken on day -1. As shown in Table 2, significant 
relationships was observed between all quality dimensions and the perceived service quality. 
Only technical quality correlated with patient throughput time.  
Table 1. Descriptive statistics 
------------------------------- 
Insert Table 1 about here 
------------------------------- 
Table 2. Internal consistency and the correlation matrix 
------------------------------- 
Insert Table 2 about here 
------------------------------- 
Effect of redesign initiatives on patient throughput time  
Table 3. Patient throughput time 
------------------------------- 
Insert Table 3 about here 
------------------------------- 
The time of blood sampling had a significant effect on throughput time (F = 32.859; p 
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< 0.001; part.ŋ2 = .105). There was no significant effect of dose banding (F = .495; p = .482; 
part.ŋ2 = .002; see Table 3). There was no interaction effect between the moment of blood 
sampling and dose banding (F = 1.151; p = .284; part.ŋ2 = .004). The model explained 20.3% 
of the variance in the throughput time (F(5, 281) = 15.604; p < .001; part.ŋ2 = .217). The model 
was controlled for the time of data collection and for the department where the data was 
collected. No control variables were significant. 
 
Effect of redesign initiatives on service quality perception 
Based on the hierarchical analysis, the control variables (moment of data collection and 
department) showed no significance (F(3,255) = 2.278; p = .079, Adj.R2 = .02) and were not 
added to the model.  
Table 4. Multiple linear regression 
------------------------------- 
Insert Table 4 about here 
------------------------------- 
We searched for the best-fitting model based on a significant R2 change (see Table 3). The 
model with only environmental quality, technical quality, and administrative quality as 
independent variables explained 62.9% of the variance in perceived service quality. This 
change in R2 became significant (p = .007) when the interaction of taking the blood sample on 
day -1 and technical quality was added. The final model explained 63.7% of the variance in 
perceived service quality. Technical quality is the most important quality dimension (B = .688), 
followed by administrative quality (B = .138), and environmental quality (B = .097). When the 
blood sample was taken on day -1, the perceived service quality per unit change in technical 
quality was on average .263 higher than when the blood sample was not taken in advance. 
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Discussion 
The results of this study demonstrate the effect of process design characteristics on the 
efficiency and quality of an organization. Taking the blood sample on day -1 does significantly 
decrease patient throughput time before the initiation of therapy on day 0. Throughput 
efficiency is thus increased and more patients can be treated per day at the department, which 
is an important performance measure for CDUs. This throughput time also includes waiting 
time for the patient, which has been identified in previous research as being not valuable for 
the patient and should thus be reduced (Masselink et al., 2012; Turkcan, Zeng & Lawley, 2012; 
van Lent et al., 2009; Vanberkel et al., 2010). 
On the other hand, dose banding has no significant effect on patient throughput time, 
although it has been identified as a strategy for accelerating in-hospital turnaround time for 
commonly used preparations that contribute to enhanced daily patient capacity in oncology 
clinics (Hoppe-Tichy, 2009). There are several reasons why dose banding does not lead to a 
reduction in patient throughput time, such as the fact that it is only possible for drugs with 
sufficient long-term stability; sometimes a mix of drugs with and without dose banding is used 
for patients who are receiving multiagent chemotherapy protocols. Nevertheless, dose banding 
does reduce throughput time in the pharmacy (Claus et al., 2018), improving organizational 
processes there, but so far the impact on the patient process in the CDU seems to be limited.  
We also investigated the impact of the redesign characteristics on the perceived service 
quality of the patient. As such, our study contributes to the debate on how measurements of 
patients’ perceptions helps understand the patient experience with regard to oncology 
processes. This is an important topic in the current discussion on patient reported experience 
measures (PREMs) (Luckett, Butow & King, 2009). Most variance in perceived service quality 
was explained by technical quality. Environmental and administrative quality were also 
significant, but interpersonal quality surprisingly was not. This is not in line with the report of 
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Dagger et al. (2007), who found that interpersonal quality had a significant effect on perceived 
service quality in a private outpatient oncology clinic. However, interpersonal and technical 
quality are both terms used to describe the competence of the medical staff. It may be that 
patients focus more on the technical quality than on the interpersonal quality on account of the 
setting. The study was carried out in a university hospital, which has more expertise in complex 
diseases and the administration of complex multiagent chemotherapy protocols. Because of the 
severity and complexity of the individual cases, patients may focus more on technical quality 
rather than interpersonal quality. As expected, dose banding did not influence the perceived 
service quality, as dose banding is an organizational issue that is not discussed with the patient 
prior to treatment, meaning the patient is not aware of whether dose banding is used to prepare 
the medication.  
When a blood sample is taken on day -1, the average increase in perceived service 
quality per unit change in technical quality is .202 greater than when the blood sample is not 
taken in advance. Although more effort is required of patients who must visit the hospital twice 
(or pay an additional visit to a general practitioner), it nonetheless affects the perception of 
technical quality positively. This might be explained by the fact that the blood sample is taken 
in a different professional environment. On day -1, the patient is typically seen by a nurse and 
a physician who discuss the treatment experience in a more general way, without focusing 
exclusively on the administration of anticancer drugs. Hence, the individual time spent with a 
practitioner on at a separate point in time is valuable for a patient.  
This study has several limitations. Our response rate (40%) was not high, but is 
nonetheless reasonable, given the requirement that both the survey and process travel sheet 
needed to be filled out correctly. The study was performed at only two CDUs at a single 
university hospital. This rather small sample size restricts the interpretation and generalization 
of the results. The quantitative method to measure perceived service satisfaction gives less 
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information about why patients perceive technical quality better when the blood sample is taken 
on day -1. A qualitative study could give more insight into this.  
Despite its limitations, the results of this study highlight several key aspects that should 
be considered in the design of cancer care services. The implementation of dose banding might 
improve performance in the pharmacy department, but has no significant impact on the CDU. 
On the other hand, taking blood samples taken on day -1 has a positive effect on both the patient 
throughput time and the perceived service quality. The throughput time of an individual patient 
is thus reduced and more patients can be treated in a single day. Although taking the blood 
sample on day -1 requires an extra effort from the patients, who must visit a professional twice, 
this nonetheless increases the perceived service quality. In conclusion, the efficiency of the 
CDU and the service quality, as perceived by the patient, can be considered to be two sides of 
the same coin.  
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Figure 1: Dimensions of service quality based on Dagger et al. (2007) 
 
Legend Figure 1: 
Illustration of the four dimensions and their subdimensions for evaluating perceived service quality. 
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Table 1. Descriptive statistics 
  Frequency  Percentage 
Time of data collection     
Time of data collection 1 163 52.9% 
Time of data collection 2 145 47.1% 
Department      
CDU1 151 49.0% 
Breast cancer 76 50% 
Head or neck cancer 16 11% 
Pelvic cancer 13 9% 
Gastroenterological cancer 11 7% 
Melanoma 10 7% 
Urological cancer 9 6% 
Sarcoma 2 1% 
Thoracic cancer 1 1% 
Genetic disorder 1 1% 
CDU2 157 51.0% 
Haematology 66 42% 
Gastroenterological cancer 78 50% 
Thoracic cancers 13 8% 
Blood sample     
Day 0 179 58.1% 
Day -1 129 41.9% 
Dose banding     
Yes 46 14.9% 
No 262 85.1% 
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Table 2. Internal consistency and correlation matrix 
Constructs M SD 
Cronbach’s 
Alpha 
1 2 3 4 5 
1. Patient throughput time 
1:56:30 ± 
0:03:49 
1:04:47 NA 
        
  
2. Administrative quality  5.34 ± 0.06 0.99 .64 .038  
  
 
3. Environmental quality 4.94 ± 0.07 1.27 .94 .097 .491*       
4. Interactional quality 5.60 ± 0.05 0.86 .70 .089 .472* .365* 
 
 
5. Technical quality 6.11 ± 0.04 0.61 .81 .121* .519* .399* .577*   
6 Perceived quality 5.96 ± 0.05 0.80   .071 .564* .489* .494* .749* 
 
Note. M = mean construct score (unweighted); SD = standard deviation; the diagonal numbers represent the 
correlations between constructs; * p < .05. 
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Table 3. Patient throughput time 
 
 
Throughput time 
 
No dose banding    Dose banding 
 
N Mean SD 
 
n Mean SD 
Day 0 152 02:18:31 01:01:42 
 
17 02:34:00 01:06:53 
Day -1 91 01:25:04 00:51:49 
 
27 01:14:48 00:54:34 
 
Legend: Throughput time related to day the blood sample was taken and the use of dose banding. 
N = number of participants; SD = Standard deviation 
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Table 4. Multiple linear regression 
  Variable  b SE(b) t p AdjR2 
Model 1      < 0.001 0.629 
  Environmental quality 0. 099 0.026 3.739  < 0.001   
  Technical quality 0.785 0.056 13.954  < 0.001   
  Administrative quality 0.140 0.036 3.865  < 0.001   
Model 2        
  Environmental quality 0.097 0.026 3.705  < 0.001 0.637 
  Technical quality 0.688 0.066 10.438  < 0.001   
  Administrative quality 0.138 0.036 3.847  < 0.001   
  
Technical quality * Blood 
sample 0.263 0.097 2.718 0.007   
 
Legend: The best fitting model based on a significant R2 was used to determine the most parsimonious model of 
perceived service quality. Model 1 evaluates administrative quality, technical quality and environmental quality 
as the independent variables and explained 63.6% of the variance in perceived service quality (p < 0.001). Model 
2, also considering the interaction effect of technical quality and the  day the blood sample was taken, explained 
64.5% of the variance in perceived service quality with a significant R2 change (p = 0.006). 
 
 
